Senior Writer, US Policy & Regulation
After moving to New York from his hometown of New Orleans, Brian worked on the East End of Long Island covering news, politics and the military. He has since covered the diamond and jewelry industries and most recently pharmacy and health care. His experience also includes freelance reporting and photography contributed to the New York Times.
Brian holds a BA in history from Loyola University of New Orleans, is a die-hard Saints fan, and loves running, classical music and jazz. He lives with his wife, Caroline, in New York’s magnificent Hudson Valley.
Latest From Brian Bossetta
The US Food and Drug Administration is alerting health care providers that some cardiac devices from a major supplier are in short supply.
The latest recall for Medtronic's HeartWare Ventricular Assist Device (HVAD) System was triggered by reports of hardened driveline boot covers, which can make disconnecting the driveline from the controller difficult.
The US FDA has approved a temporary prostatic stent from SRS Medical Systems that allows urine to flow through the urethra when it is blocked by an enlarged prostate.
Now that the CHIPS and Science Act is law, AdvaMed wants the Biden administration to use it to ensure device makers get the semiconductor chips they need for their products while preventing the US from facing another shortage of the essential components, as experienced during the pandemic.
Compatibility Issues With Some LAV Connectors And Prefilled Syringes Can Interrupt Drug Delivery, FDA Warns
The US FDA says issues with certain LAV connectors attached to prefilled glass syringes may cause clogging and prevent the proper administration of drugs. This could result in serious harm, especially during emergencies.
The US FDA has cleared an AI-based diagnostic from Israeli firm AEYE Health that screens for diabetic retinopathy, a leading cause of blindness.